Late occurrence of Epstein-Barr virus-associated lymphoproliferative disorder in a patient with follicular lymphoma treated with bendamustine and rituximab - 坂田（柳元） 麻実子; 佐藤 泰樹; 横山 泰久; 栗田 尚樹; 小原 直; 長谷川 雄一; 野口 雅之; 千葉 滋; Muroi Kei; Sakata-Yanagimoto Mamiko; Sato Taiki; Yokoyama Yasuhisa; et al. (Annals of hematology, 2015)
Keywords: Antineoplastic Combined Chemotherapy Protocols - administration & dosage; Antineoplastic Combined Chemotherapy Protocols - adverse effects; Bendamustine Hydrochloride - administration & dosage; Bendamustine Hydrochloride - adverse effects; Epstein-Barr virus; Epstein-Barr Virus Infections - chemically induced; Female; Hematology; Herpesvirus 4, Human; Humans; Letter to the Editor; Lymphoma, Follicular - drug therapy; Lymphoma, Follicular - virology; Medicine; Medicine & Public Health; Middle Aged; Oncology; Rituximab - administration & dosage; Rituximab - adverse effects; Lymphoproliferative Disorder; Follicular Lymphoma; Bendamustine; Progressive Multifocal Leukoencephalopathy; Axillary Lymph Node